ATP-BINDING CASSETTE SUBFAMILY C MEMBER 6 DEFICIENCY
Clinical trials for ATP-BINDING CASSETTE SUBFAMILY C MEMBER 6 DEFICIENCY explained in plain language.
Never miss a new study
Get alerted when new ATP-BINDING CASSETTE SUBFAMILY C MEMBER 6 DEFICIENCY trials appear
Sign up with your email to follow new studies for ATP-BINDING CASSETTE SUBFAMILY C MEMBER 6 DEFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for babies with rare calcification disease: first drug trial launches
Disease control Recruiting nowThis study tests a new drug called INZ-701 in up to 16 infants (up to 1 year old) with rare genetic conditions (ENPP1 or ABCC6 deficiency) that cause dangerous calcium buildup in arteries and other problems. The main goal is to check the drug's safety and how the body handles it,…
Matched conditions: ATP-BINDING CASSETTE SUBFAMILY C MEMBER 6 DEFICIENCY
Phase: PHASE1 • Sponsor: Inozyme Pharma • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New registry aims to unlock secrets of rare genetic diseases
Knowledge-focused Recruiting nowThis observational registry is collecting information from up to 1,000 people with ENPP1 deficiency or infantile-onset ABCC6 deficiency. The goal is to understand how these rare diseases progress over time by tracking genetic, physical, and quality-of-life changes during routine …
Matched conditions: ATP-BINDING CASSETTE SUBFAMILY C MEMBER 6 DEFICIENCY
Sponsor: Inozyme Pharma • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC